Company intelligence / Profile preview

Medsin

Obour City, Cairo, Egypt

Ownership: Private
Development stage: Other

Overview

Medsin Pharmaceutical Industries is an Egyptian pharmaceutical company focused on the development, manufacturing, and marketing of high-quality generic medicines. Headquartered in Cairo with manufacturing facilities in Obour City, the company produces a diverse portfolio of therapeutic products including antibiotics, analgesics, and treatments for chronic conditions. Medsin operates with a focus on providing affordable healthcare solutions to the Egyptian market and neighboring regions. The company maintains modern production lines that adhere to Good Manufacturing Practice (GMP) standards to ensure product safety and efficacy.

Therapeutic areas: CardiovascularNeurologyInfectious DiseasesPulmonologyGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Medsin.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medsin.

Explore the full profile